MEDICATION MANAGEMENT AND QUALITY USE OF MEDICINES
Dr Manya Angley, Adjunct Professor,
School of Health and Clinical Sciences, Health Professions Education,
University of Western Australia &
Director,
Manya Angley Research and Consulting (MARAC),
Adelaide, South Australia
RESEARCHER PROFILE
Filmed in Adelaide, Australia | July 2026
Adjunct Professor Manya Angley is an Advanced Practice Pharmacist. Manya spent the first 20 years of her career as a teaching and research academic at the University of South Australia. She currently works as a credentialed pharmacist and researcher through her business, Manya Angley Research and Consulting (MARAC).
Her professional activities are focused in general practice, disability and aged care. She continues to undertake research in medicines safety at care transitions and quality use of medicines in the aged care and disability sectors. Manya has just stepped down as SA/NT Branch President of the Pharmaceutical Society of Australia (July 2023-June 2026) was previously vice-president (2022-2023).
Manya was the proud recipient of the Pharmaceutical Society of Australia (SA/NT Branch) Pharmacist of the Year (2021) and the Australian Association of Consultant Pharmacy MIMS Consultant Pharmacist of the Year (2021).
Manya holds, or has held, positions on various multidisciplinary Department of Health, Disability and Ageing (DoHDA) and the ACSQHC technical expert committees. She is regularly invited to present at National pharmacy conferences and to present to other disciplines.
Manya was appointed an Adjunct Professor at the University of Western Australia in 2025.
Source: Supplied
SEE OTHER RESEARCHER PROFILES
Bench Side Story @BenchSideStory
https://t.co/vzQCTpFOVv
Get your own interviews and research published on Bench Side Story
https://t.co/Qrj09SzaeC
Time for a medicines stewardship approach to transitions-of-care, to address the intractable problem of medication errors and harms following hospital discharge. Editorial with @ManyaAngley@Deequm@JonPenm@ShaniaLiu_ https://t.co/Z2AMMRPwOZ
New journal issue release! The August issue of #AustralianPrescriber highlights the pharmacological management of polycystic ovary syndrome, safe medication management during transitions of care, a judicious approach to investigations for inflammatory arthritis, and more.
Plus, stay informed with our commentary on new drugs. Check out the August issue now! https://t.co/6S20PsNkcg
@Mark_Butler_MP#PSA24 “With the aging population & rising rates of chronic disease, all health professionals need to be operating at their full scope. Yet, there is a glass ceiling, due to turf protection/vested interests. We’ve got to bust through this old fashioned thinking”
Congratulations @JacintaAdelaide on being named a 2024 SA Young Tall Poppy!
She is leading a trial of a model of care, where #pharmacists work with doctors to electronically prescribe #medicines, proactively to prevent errors and other problems from occurring.
@UniversitySA
Great to see this published! Congratulations @Dorsa_Maher😀
Mapping antimicrobial prescribing, supply, administration & documentation in #RACFs to inform #surveillance of use. So complex! Many areas to improve antimicrobial management #AMS#AMR@JAMDAcom https://t.co/pE2SPJ3Rhn
Rod Carracher, A/Deputy Commissioner, Practice Quality, NDIS Quality and Safeguards Commissioner, says psychotropic medicines must not be the 'go-to' for addressing behaviours of concern for people with disability.
https://t.co/LwI66wJxMS
#PsychotropicMedsCCS
Prof Julian Trollor, Chair Intellectual Disability Mental Health @UNSW says responsible psychotropic prescribing is critical to ensuring better health outcomes for people with cognitive disability or impairment.
See the new national #PsychotropicMedsCCS https://t.co/LwI66wJxMS
A/Professor Juanita Breen says, "When psychotropics are used to influence behaviour whether in dementia or intellectual disability, the risk of harm often outweighs the benefits – especially for less severe presentations."
#PsychotropicMedsCCS https://t.co/LwI66wJxMS @UTAS_